Joseph Nolan, MD
Interventional Pain Medicine · N Charleston, SCNPI 1679576813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,128 and has fallen 82.3% since, to $200 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in SC, where the typical reported total is $3,940.
Across 140 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$859
- Collegium Pharmaceutical, Inc.$252
- AbbVie$244
- Vertos Medical, Inc.$176
- Pfizer$174
- Scilex Pharmaceuticals Inc.$171
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,74699%
- Education$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $859 |
| Collegium Pharmaceutical, Inc. | 16 | $252 |
| AbbVie | 7 | $244 |
| Vertos Medical, Inc. | 3 | $176 |
| Pfizer | 12 | $174 |
| Scilex Pharmaceuticals Inc. | 11 | $171 |
| MML US, Inc. | 1 | $165 |
| Tersera Therapeutics LLC | 8 | $165 |
| Flowonix Medical Incorporated | 1 | $142 |
| GRT US Holding, Inc. | 2 | $138 |
| Forte Bio-pharma LLC | 2 | $121 |
| IBSA Pharma Inc. | 7 | $119 |
| Electronic Waveform Lab, Inc. | 3 | $96 |
| Boston Scientific | 1 | $89 |
| Virtus Pharmaceuticals LLC | 5 | $82 |
| Arbor Pharmaceuticals, Inc. | 6 | $78 |
| Biohaven Pharmaceuticals, Inc. | 4 | $76 |
| Protega Pharmaceutials Inc | 4 | $65 |
| Smith+Nephew | 3 | $63 |
| Redhill Biopharma Inc. | 3 | $59 |
| Painteq LLC | 1 | $54 |
| Pacira Therapeutics, Inc. | 3 | $53 |
| Sentynl Therapeutics, Inc. | 3 | $47 |
| AstraZeneca | 3 | $42 |
| Nevro Corp. | 3 | $39 |
| Zyla Life Sciences, Inc. | 1 | $37 |
| Eisai Inc. | 2 | $30 |
| Bioventus LLC | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Amgen | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Abbott | 1 | $13 |
| Si-bone, Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $12 |
| MDD US Operations, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$230
- ReActiv8$165
- SYNCHROMEDII$153
- Prometra II$142
- RESTORE$140
- Qutenza$120
- mild Device Kit$114
- UBRELVY$109
How this compares
$3,782 in reported general payments places this provider in the 45th percentile of 38 interventional pain medicine providers in South Carolina.
See all interventional pain medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 21 | $14,612 |
| Hydrocodone Bitartrate ErHydrocodone Bitartrate | 12 | $5,158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $3,097 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $2,978 |
| Tizanidine Hcl | 106 | $2,277 |
| Lidocaine | 19 | $1,990 |
| Gabapentin | 83 | $1,142 |
| Oxycodone Hcl | 41 | $814 |
| Lubiprostone | 14 | $801 |
| Naloxone Hcl | 12 | $760 |
| Duloxetine Hcl | 67 | $746 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $725 |
| Morphine Sulfate | 22 | $666 |
| Cyclobenzaprine Hcl | 43 | $481 |
| Trazodone Hcl | 20 | $440 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $252 | $14,61221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 38 interventional pain medicine providers in South Carolina.
Other interventional pain medicine in N Charleston
- Mark NethertonMt Pleasant$102K
- Marion McMillanSeneca$89K
- Jason RosenbergMurrells Inlet$82K
- Ryan NoblesMt Pleasant$43K
- Justin HutchesonGreenville$23K
- Joshua BighamSpartanburg$14K
- David RoweBluffton$9K
- William DurrettAiken$8K
- Kenneth GrosslightWest Columbia$7K
- Phillip SuwanAiken$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.